-
Eyre Ophthalmology acquires ISEC Healthcare, an ophthalmology clinic
Time of Update: 2021-02-28
ISEC Healthcare's ophthalmologists work with renowned Malaysian university medical schools to provide patients with specialized ophthalmology and care services.
-
Jining implements the centralized drug procurement policy
Time of Update: 2021-02-28
with the lowest purchase price of the same drug in the expanded area in 2018. In April this year, Jining City on time to implement the country's second batch of drug centralized procurement policy, from sugar-reducing heat
-
The new coronavirus may enter the brain through the nose
Time of Update: 2021-02-28
The researchers also found new coronavirus tingling proteins in specific cell types of the olfactory mucosa, which use the endoder and adjacent nerve tissue to enter the brain.
-
The relationship between the counterparts is adjusted again
Time of Update: 2021-02-28
2019, negotiate to determine a number of support relationship in the main responsibility of the hospital, clearly help the overall goal, develop an annual help plan, quantitative evaluation indicators. "Notice" stressed that in the process
-
Shandong expands the scale of targeted training of public-funded orders for rural medical students
Time of Update: 2021-02-28
Lixin, deputy director of the Shandong Provincial Health and Family Planning Commission, said that Shandong has implemented a public-funded training program for targeted medical students for rural orders, with 1,000 undergraduate students enrolled each year for five-year courses.
-
Gilead is interested in acquiring a partial interest in io's arcus
Time of Update: 2021-02-28
in China have ended this week because of a recruitment challenge. Two Phase III clinics in the U.S. have also recently significantly increased the number of patients and altered clinical endpoints, making experts suspect limited efficacy. The new crown
-
Sci Transl Med: Scientists hope to use a new smartphone to help monitor the progression of Parkinson's disease
Time of Update: 2021-02-28
9, 2021 // -- In a study published in the international journal Science Translational Medicine, Apple Inc. and several research institutions in the United States have jointly developed a smartwatch that may provide valuable resources to help track
-
The latest official response from Huahai Pharmaceuticals has come after the recall
Time of Update: 2021-02-28
, and that the impurity could pose any risk to the patient, which the EMA would inform in the first place. At present, national registration regulations have not yet issued standards for the acceptable control limits of NDMA impurities produced in this production process
-
The 2nd Wu Zhengxuan Botany Award was announced
Time of Update: 2021-02-28
, potato The development and utilization of such resources has made great achievements, the development of new drugs such as tympphrine, miyagi ning and other new drugs, domestic potato sacin, autumn daffodils, 37 saponin and other pharmaceutical raw
-
From the synthesis of a protein to the synthesis of life, Shanghai leads the life sciences
Time of Update: 2021-02-28
just last year, two life sciences achievements from Shanghai, the world's first sophyte cloned monkeys and the first international artificial creation of a single chromosome total nucleus, topped China's top 10 scientific and technological advances in 2018.
-
Cell: Common fungi in the gut are like vaccines and can cause an immune response to prevent pathogenic fungal infections
Time of Update: 2021-02-28
dangerous relatives. failures in this process can make people vulnerable to deadly fungal infections. it reveals a new twist in the complex relationship between humans and their associated microbes and points the way for the development
-
Hengrui's market capitalization broke 300 billion pharmaceutical companies ranked reshuffle
Time of Update: 2021-02-28
Hengrui Pharmaceuticals has invested 98 million yuan in the research and development project of sulfur-pei non-Gestin injection, which is expected to drive the company's performance growth after listing.
-
Brand for the Wang era Tu enterprises to strengthen the brand strategy
Time of Update: 2021-02-28
in the brand for the king today, paint enterprises must strengthen the management of brand strategy.
-
The 42 diseases in Fujian Province began to be paid for by disease
Time of Update: 2021-02-28
to as Notice) will once again pay by disease to the deep water area: wheezing, fractures, cough disease, kidney failure, heart failure, low back pain, stroke, disease and other 42 kinds of diseases will be implemented in Fujian Province pay-per-view
-
Rgenta completes $20 million seed round financing
Time of Update: 2021-02-28
RNA-targeted drugs bring new changes to drug development, Rgenta has built an innovative and unique technology platform For small molecule therapies, the vast majority of their targets are proteins.
-
The total industrial output value of Yunnan biopharmaceutical industry is 46.5 billion yuan
Time of Update: 2021-02-28
., focusing on natural medicine (Chinese medicine). Next, Yunnan will actively promote reform measures such as management services, innovate regulatory methods, enhance regulatory effectiveness, strengthen service guidance, promote cross-regional, cross
-
Half a year later, the three pharmaceutical companies will finally be sold
Time of Update: 2021-02-28
lines can produce 80 million powder needles / year, 60 million small-capacity injections / year, 30 million freeze-dried powder needles / year, sterile API 5000 kg / year, annual output value of hundreds of millions of yuan. combined
-
Hengrui Pharmaceuticals' share price rose to become the first pharmaceutical company to break 300 billion A-shares
Time of Update: 2021-02-28
of 13.836 billion yuan, net profit of 3.217 billion yuan, in the 18 years of listing, respectively, increased about 28 times, 48 times, while the share price increased by more than 250 times, far higher than the performance growth. On June 12
-
"With gold" sales lost the four basic skills necessary for pharmaceutical people
Time of Update: 2021-02-28
ability of substitutes, supplier bargaining power, buyer's bargaining power and other five forces; 03, fast and effective dissemination of brand “ Passing "word to the left side, to the right side
-
The effect of Paboliju monoantigen or combined beva bead monoantigen treatment of recurrence GBM was not good
Time of Update: 2021-02-28
VEGF inhibitor bevacizumab can prolong the progression-free survival of relapsed glioblastoma, and beva bead monoantigen can also inhibit tumor growth through a variety of mechanisms.
